ライフサイエンスコーパス: pulmonary complication

1 icians must remain vigilant to its potential pulmonary complication.

2 cell transplantation rapidly corrected this pulmonary complication.

3 toperative recovery and a marked decrease in pulmonary complications.

4 offer the potential of decreasing associated pulmonary complications.

5 xperience an increased risk of perioperative pulmonary complications.

6 tive hypoxemia, Sao2 level, or postoperative pulmonary complications.

7 predisposed to infectious and noninfectious pulmonary complications.

8 idural analgesia in preventing postoperative pulmonary complications.

9 atric surgery at high risk for postoperative pulmonary complications.

10 ith underlying conditions, for postoperative pulmonary complications.

11 to clearly or possibly reduce postoperative pulmonary complications.

12 ith increased mortality, which may be due to pulmonary complications.

13 of the evidence of interventions to prevent pulmonary complications.

14 patients at risk of developing postoperative pulmonary complications.

15 gic perturbations, and its ability to reduce pulmonary complications.

16 e to factors aimed at reducing postoperative pulmonary complications.

17 n these patients and increasing the risk for pulmonary complications.

18 bclinical population of patients at risk for pulmonary complications.

19 s not associated with clinically significant pulmonary complications.

20 lation with the development of postoperative pulmonary complications.

21 nal failure, septic shock, and postoperative pulmonary complications.

22 anged from 0.757 for infectious to 0.897 for pulmonary complications.

23 with death in the first decade due to cardio-pulmonary complications.

24 ssure are associated with more postoperative pulmonary complications.

25 associated with fewer severe infections and pulmonary complications.

26 ical outcomes, and management of cardiac and pulmonary complications.

27 ay lead to reduction of severe postoperative pulmonary complications.

28 ood of OSA, postoperative desaturations, and pulmonary complications.

29 per year, P < 0.001) independently predicted pulmonary complications.

30 e times and the rate of 30-day postoperative pulmonary complications.

31 ary to reduce the incidence of postoperative pulmonary complications.

32 who are at increased risk for postoperative pulmonary complications.

33 The sample allowed a 75% power to detect pulmonary complications (1% vs. 5%) between the two trea

34 perative bleeding (17%), septic shock (16%), pulmonary complications (15%), and organ-space infection

35 Twenty-six had pulmonary complications (19%).

36 Pulmonary complications (23.9%), renal failure (12.5%),

37 morbidity (>/=grade III), mostly related to pulmonary complications (25.7%), anastomotic leakage (15

38 trial arrhythmia (27% vs 19%; P = 0.013) and pulmonary complications (27% vs 20%; P = 0.016).

39 gastrointestinal complications (11.3%), and pulmonary complications (3.6%).

40 The leading causes of hospital death were pulmonary complications (45.5%) and progression of malig

41 participants; OR, 0.26; 95% CI, 0.09-0.76), pulmonary complications (9 studies, 1019 participants; O

42 Pulmonary complications account for significant morbidit

43 Outcomes examined included bacteremia, pulmonary complications, acute renal failure, shock, int

44 enhance physician awareness of postoperative pulmonary complications, advance postoperative pulmonary

45 olitis obliterans (BO) is a detrimental late pulmonary complication after allogeneic hematopoietic st

46 arterial oxygen saturation (Sao2) level, and pulmonary complications after bariatric surgery.

47 e ventilation has been recommended to reduce pulmonary complications after cardiac surgery.

48 d 400 adults at intermediate to high risk of pulmonary complications after major abdominal surgery to

49 allow risk stratification for postoperative pulmonary complications after noncardiothoracic surgery.

50 ient- and procedure-related risk factors for pulmonary complications after surgery, the role of preop

51 factors for the development of postoperative pulmonary complications allows targeted interventions ai

52 The influence of this pulmonary complication, along with the omission of bleom

53 cted individuals is associated with multiple pulmonary complications and a poor prognosis.

54 spirometry decreases rates of postoperative pulmonary complications and hospital lengths of stay.

55 Pulmonary complications and hypoxemia are common in sick

56 6.9; P < 0.05) and an increased incidence of pulmonary complications and increased hospital costs.

57 dy presents an estimate for both severity of pulmonary complications and intensity of respiratory the

58 stomosis, methods to reduce the incidence of pulmonary complications and optimizing fluid management

59 me and the association between occurrence of pulmonary complications and outcome in these patients.

60 survival rate of BMT patients who developed pulmonary complications and required mechanical ventilat

61 roach has been shown to reduce postoperative pulmonary complications and shorten hospital length of s

62 ve shown that MIE is associated with reduced pulmonary complications and shorter hospital stay as com

63 w will discuss the etiology of postoperative pulmonary complications and the interventions that reduc

64 e of clinical risk factors for postoperative pulmonary complications and the value of preoperative te

65 a to reduce postoperative cardiovascular and pulmonary complications and there is also consistent evi

66 sthetic techniques in reducing postoperative pulmonary complications, and also to define the nature o

67 [PEEP] expressed as cm H2O), development of pulmonary complications, and clinical outcomes.

68 ganisms were less likely to have bacteremia, pulmonary complications, and shock, and were less likely

69 Postoperative pulmonary complications are a major contributor to the o

70 Postoperative pulmonary complications are as frequent and clinically i

71 Postoperative pulmonary complications are as prevalent as cardiac comp

72 Pulmonary complications are common after coronary artery

73 Pulmonary complications are common following hematopoiet

74 Postoperative pulmonary complications are common in patients with Amer

75 Postoperative pulmonary complications are common, are associated with

76 Pulmonary complications are common.

77 Transfusion-related pulmonary complications are leading causes of morbidity

78 ith good pulmonary reserve, if postoperative pulmonary complications are reduced, or if complications

79 Other than relapse, pulmonary complications are the most common cause of mor

80 lmonary complications, advance postoperative pulmonary complications as a substantive public health c

81 of inflammation, causing unexplained chronic pulmonary complications as seen in some patients during

82 supporting strategies to reduce the risk of pulmonary complications as they apply to Mr A.

83 n, etoposide and platinum (BEPx4) to prevent pulmonary complications, as these patients require exten

84 iplinary team developed a strategy to reduce pulmonary complications based on comprehensive patient a

85 There was a dose-dependent increase in pulmonary complications based on pack-year exposure with

86 lications with abdominal wound infection and pulmonary complications being the 2 most frequent.

87 Postoperative pulmonary complications can be a devastating consequence

88 the incidence of serious cardiovascular and pulmonary complications can be minimized.

89 Pulmonary complications comprised fungal (n = 11), viral

90 Severity of postoperative pulmonary complications computed until hospital discharg

91 Pulmonary complications contribute significantly to rheu

92 Noninfectious pulmonary complications develop frequently in blood and

93 Rates of 30-day postoperative pulmonary complications did not differ between groups (8

94 Amiodarone has been known to cause pulmonary complications; especially in those with COPD a

95 type I IFN-mediated mechanisms can determine pulmonary complications from Pneumocystis infection.

96 nique over another in reducing postoperative pulmonary complications has not been demonstrated.

97 Cardiac and pulmonary complications have been markedly reduced, wher

98 red immunodeficiency syndrome (AIDS)-related pulmonary complications, human immunodeficiency virus-po

99 Acute lung injury (ALI) is a frequent pulmonary complication in critically ill patients.

100 aspergillosis is a Th2 T-lymphocyte-mediated pulmonary complication in patients with atopic asthma an

101 ent of highly active antiretroviral therapy, pulmonary complications in AIDS are a common clinical pr

102 Late pulmonary complications in bone marrow or stem cell tran

103 To determine the pulmonary complications in HIV-1-infected patients in Da

104 n between tidal volume and the occurrence of pulmonary complications in ICU patients without acute re

105 When examining pulmonary complications in patients with FEV1 less than

106 sociated with a lower risk of development of pulmonary complications in patients without acute respir

107 There were no cardiac or pulmonary complications in the lumpectomy group.

108 ion and causes a range of cardiovascular and pulmonary complications in vivo.

109 The most commonly seen pulmonary complications include pleural effusion, hemoth

110 Postoperative pulmonary complications included those defined by the ST

111 tient-related risk factors for postoperative pulmonary complications, including advanced age, America

112 Infection by HIV-1 frequently leads to pulmonary complications, including alterations to local

113 edure-related risk factors for postoperative pulmonary complications, including aortic aneurysm repai

114 urrence and is associated with postoperative pulmonary complications, including aspiration, pneumonia

115 nts are at increased risk for development of pulmonary complications, including chronic obstructive p

116 Postoperative pulmonary complications, including pneumonia, bronchospa

117 Pulmonary complications, including pulmonary fibrosis (P

118 ciated with sleep disturbances, tachycardia, pulmonary complications, increased stress response with

119 ed preoperatively, the rate of postoperative pulmonary complications is low and not associated with O

120 The treatment of noninfectious pulmonary complications is not based on randomized clini

121 s patients at highest risk for postoperative pulmonary complications is the need for postoperative me

122 However, the risk of pulmonary complications is very small and outweighed by

123 Late-onset noninfectious pulmonary complications (LONIPCs) after allogeneic hemat

124 Pulmonary complications may even be more likely than car

125 ty, wound complications, general infections, pulmonary complications, neurological complications, and

126 herapy was well tolerated with no infectious pulmonary complications noted.

127 Pulmonary complications occur frequently in patients at

128 reased risk of infection, and in particular, pulmonary complications occur frequently.

129 Cardiac and pulmonary complications occurred infrequently in the mas

130 TEP was also associated with a lower rate of pulmonary complications (odds ratio = 0.655; 95% confide

131 ciated with the development of postoperative pulmonary complications (odds ratio [OR] for one unit in

132 ic pneumonia syndrome (IPS), a noninfectious pulmonary complication of allogeneic bone marrow transpl

133 veolar hemorrhage (DAH) is one noninfectious pulmonary complication of BMT.

134 Bronchopulmonary dysplasia is a common pulmonary complication of extreme prematurity.

135 BPD) is a prevalent yet poorly characterized pulmonary complication of premature birth; the current d

136 Pulmonary complications of cancer treatment have proven

137 ymptomatic HIV-infected individuals from the Pulmonary Complications of HIV Infection Study cohort, p

138 The Pulmonary Complications of HIV Infection Study is a pros

139 synthetic glucocorticoids for management of pulmonary complications of HIV infection.

140 y for a potential pathogenic role in chronic pulmonary complications of HIV infection.

141 To define the pulmonary complications of influenza during the current

142 A review of the literature shows that pulmonary complications of P. vivax are rare but occur m

143 ped iBALT is most prevalent in patients with pulmonary complications of RA and Sjogren syndrome.

144 The pulmonary complications of SCD are of particular importa

145 The pulmonary complications of sickle cell disease include a

146 gans affected in sickle cell disease and the pulmonary complications of sickle cell disease result in

147 cases of female patients presenting typical pulmonary complications of the hyper-Ig E syndrome.

148 l to the community setting, knowledge of the pulmonary complications of transplantation is increasing

149 duce the deleterious impact of postoperative pulmonary complications on clinical outcomes and healthc

150 obesity did not predispose toward increased pulmonary complications or deep sternal wound infection

151 ssure was associated with more postoperative pulmonary complications (OR 3.11, 95% CI 1.39-6.96; p=0.

152 emia (OR, 0.54; 95% CI, 0.31-0.94; P = .03), pulmonary complications (OR, 0.62; 95% CI, 0.41-0.95; P

153 of protective ventilation on development of pulmonary complications (p=0.027).

154 Postoperative pulmonary complications play an important role in the ri

155 fection, neurologic decompensation (stroke), pulmonary complication (pneumonia, atelectasis, and prol

156 ain outcome was development of postoperative pulmonary complications (postoperative lung injury, pulm

157 er liver transplantation (LT), postoperative pulmonary complications (PPC) occur in approximately 35%

158 Postoperative pulmonary complications (PPCs) after surgery are associa

159 idney function on the risk of post-operative pulmonary complications (PPCs) is not well known.

160 Postoperative pulmonary complications (PPCs), a leading cause of poor

161 (CCI), Clavien-Dindo complication (CDC), and pulmonary complications (PPCs).

162 ty, general infections, wound complications, pulmonary complications, prolonged stay at the hospital,

163 Pulmonary complications ranging from atelectasis to acut

164 Pulmonary complication rate did not differ between group

165 Pulmonary complication rate was 39% in repairs versus 32

166 Pulmonary complication rates did not differ between grou

167 e to a number of complications, particularly pulmonary complications related to scoliosis surgery, em

168 Pulmonary complications result in mortality in adults wi

169 No infections or embolic or pulmonary complications resulted from intra-arterial spl

170 omplications (RR = 1.23; 95% CI: 1.09-1.40), pulmonary complications (RR = 1.80; 95% CI: 1.30-2.49),

171 ral infections (RR=1.54, 95% CI: 1.32-1.79), pulmonary complications (RR=1.73, 95% CI: 1.35-2.23), ne

172 1.7 to 2.0) and a median 1.7 (IQR, 1.0-2.0) pulmonary complications score vs 2.1 (95% CI, 2.0-2.3) a

173 The primary endpoint was postoperative pulmonary complications; secondary endpoints were morbid

174 ) to detect ordinal shift in distribution of pulmonary complication severity score (0-to-5 scale, 0,

175 Over the last century, three pulmonary complications specific to chronic liver diseas

176 ortal hypertension present with three unique pulmonary complications that are the subject of ongoing

177 microflora, which may contribute to chronic pulmonary complications that increasingly are being reco

178 The main noninfectious pulmonary complications that present as pulmonary infilt

179 In a multivariable model of pulmonary complications, thoracotomy approach (OR = 1.25

180 es for preventing acute pancreatitis and its pulmonary complication via upregulation of HO-1.

181 The overall rate of pulmonary complications was 21.7% (1832/8439) and 17.8%

182 Occurrence of pulmonary complications was associated with a lower numb

183 mplications, primarily severe dysphagia, and pulmonary complications were more common after endoscopi

184 lation-based study showed that mortality and pulmonary complications were similar for OE and MIE.

185 Pulmonary complications were the most common (n = 1464)

186 thoracotomy patients have markedly increased pulmonary complications when compared with VATS patients

187 ruitment strategy could reduce postoperative pulmonary complications, when added to a protective vent

188 Paramount among these are pulmonary complications, which arise as a consequence of

189 recruitment strategy resulted in less severe pulmonary complications while in the hospital.

190 ed immune deficiency syndrome (AIDS)-related pulmonary complications, with a CD4+ T-lymphocyte count